Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Skin Neoplasms × Ipilimumab × Clear all

Phase

Phase 2 5 Phase NA 3 Phase 1 3 Phase 3 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Melanoma 2 Skin Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Sirolimus 3 aldesleukin 2 Tacrolimus 2 Cyclosporine 2 relatlimab 1 abobotulinumtoxinA 1 Vemurafenib 1 Sodium Chloride 1 Prednisone 1 Nivolumab 1 Mycophenolic Acid 1 Meloxicam 1 Ipilimumab 1 Interleukins 1 Interleukin-2 1 Everolimus 1 Bleomycin 1 Azathioprine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01856023 2023-12-05

PROCLIVITY02

Clinigen, Inc.

Phase 4 Terminated

29 enrolled 9 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡